Literature DB >> 10425120

Synthesis and biological evaluation of analogues of cryptolepine, an alkaloid isolated from the Suriname rainforest.

S W Yang1, M Abdel-Kader, S Malone, M C Werkhoven, J H Wisse, I Bursuker, K Neddermann, C Fairchild, C Raventos-Suarez, A T Menendez, K Lane, D G Kingston.   

Abstract

Bioassay-guided fractionation of an extract of a mixture of Microphilis guyanensis and Genipa americanacollected in the rainforest of Suriname yielded the known alkaloid n class="Chemical">cryptolepine (2) as the major active compound in a yeast bioassay for potential DNA-damaging agents; the same compound was later reisolated from M. guyanensis. The structure of cryptolepine was identified unambiguously by spectral data and by its total synthesis. Several cryptolepine derivatives (3-29, 32-41) were synthesized based on modifications of the C-2, N-5, N-10, and C-11 positions. Two cryptolepine dimers (30, 31) were also prepared. The structure modifications did not result in compounds with a higher potency than the parent compound cryptolepine in the yeast assay system, although some derivatives did show significant activity. Selected compounds (6, 7, 17, 22, 23, 26, and 27) were also tested for cytotoxicity in mammalian cell culture, and two compounds showed significant cytotoxic activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10425120     DOI: 10.1021/np990035g

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  6 in total

1.  Synthesis and evaluation of isosteres of N-methyl indolo[3,2-b]-quinoline (cryptolepine) as new antiinfective agents.

Authors:  Xue Y Zhu; Leroy G Mardenborough; Shouming Li; Abdul Khan; Wang Zhang; Pincheng Fan; Melissa Jacob; Shabana Khan; Larry Walker; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2006-11-01       Impact factor: 3.641

Review 2.  Indolo[3,2-b]quinolines: synthesis, biological evaluation and structure activity-relationships.

Authors:  Eyunni V K Suresh Kumar; Jagan R Etukala; Seth Y Ablordeppey
Journal:  Mini Rev Med Chem       Date:  2008-06       Impact factor: 3.862

3.  Biodiversity conservation and drug discovery: Can they be combined? The Suriname and Madagascar experiences.

Authors:  Shugeng Cao; David G I Kingston
Journal:  Pharm Biol       Date:  2009-08-01       Impact factor: 3.503

4.  Responses of genes involved in cell cycle control to diverse DNA damaging chemicals in human lung adenocarcinoma A549 cells.

Authors:  Huijun Zhu; Catherine Smith; Charles Ansah; Nigel J Gooderham
Journal:  Cancer Cell Int       Date:  2005-08-24       Impact factor: 5.722

Review 5.  The azaindole framework in the design of kinase inhibitors.

Authors:  Jean-Yves Mérour; Frédéric Buron; Karen Plé; Pascal Bonnet; Sylvain Routier
Journal:  Molecules       Date:  2014-11-28       Impact factor: 4.411

Review 6.  Cancer and apoptosis: The apoptotic activity of plant and marine natural products and their potential as targeted cancer therapeutics.

Authors:  Gul-E-Saba Chaudhry; Abdah Md Akim; Yeong Yik Sung; Tengku Muhammad Tengku Sifzizul
Journal:  Front Pharmacol       Date:  2022-08-10       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.